Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 110 followers
Latest posts
Last updated about 15 hours ago
Human medicines European public assessment report (EPAR): Rivaroxaban Accord, rivaroxaban, Date of authorisation: 16/11/2020, Revision: 5, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Rivaroxaban Accord, rivaroxaban, Date of...
Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 11, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 20, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of...
Human medicines European public assessment report (EPAR): Attrogy, diflunisal, Date of authorisation: 17/07/2025, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Attrogy, diflunisal, Date of authorisation...
Human medicines European public assessment report (EPAR): Afinitor, everolimus, Date of authorisation: 02/08/2009, Revision: 32, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Afinitor, everolimus, Date of authorisation...
Pre-authorisation guidance under the Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6)
about 22 hours ago
Pre-authorisation guidance under the Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6)
Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 13, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation...
Organisation chart: Administration and Corporate Management
about 23 hours ago
Organisation chart: Administration and Corporate Management
Human medicines European public assessment report (EPAR): Icatibant Accord, icatibant, Date of authorisation: 16/07/2021, Revision: 2, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Icatibant Accord, icatibant, Date of...
Human medicines European public assessment report (EPAR): Nilotinib Accord, nilotinib, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Nilotinib Accord, nilotinib, Date of...
Human medicines European public assessment report (EPAR): Tabrecta, capmatinib, Date of authorisation: 20/06/2022, Revision: 4, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Tabrecta, capmatinib, Date of authorisation...